Radiation Dose Summary for Diagnostic Procedures on FHIR
0.1.0 - ci-build International flag

Radiation Dose Summary for Diagnostic Procedures on FHIR, published by HL7 International / Imaging Integration. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-radiation-dose-summary-ig/ and changes regularly. See the Directory of published versions

Background

This chapter describes the scope of this guide, provides background information about the radiation dose summary IG, key concepts, and describes the use cases supported by this implementation guide.

  1. Problem - Description of the problem
  2. Scope - Scope of the IG
  3. Use case - Key use case covered by the IG
  4. Minimal Radiation Information - Description of data shared through this IG
  5. Underlying specifications - Description of the underlying specifications and resources.
  6. Glossary - Glossary of terms used in this IG
  7. References - Useful references

Problem

The IHE Dose Reporter actor within the IHE (Radiation Exposure Monitoring) REM profile gathers radiation information and dose reports from modalities. However, there is no standard to expose a dose summary to third parties in a light API based format.

Problem


Note: This IG also supports the summary of Radiopharmaceutical dose (not depicted above), in which Radiopharmaceutical Activity Information is provided to the Dose Info Reporter by the Radiopharmaceutical Activity Supplier. See IHE REM for Nuclear Medicine (REM-NM) for more information.

The Dose Reporter (a.k.a. Dose Management system) needs to share information related to exam dose to multiple systems outside the REM profile.

Radiation Dose Structured Reports (RDSRs) and Radiopharmaceutical Radiation Dose SRs (RRDSRs) have a complete and stable structure for recording dose information however, many Radiology Information (RIS) and Electronic Health Record (EHR) systems lack the capability to consume them. In most cases, the RIS/EHR need are light, requiring only a dose summary for inclusion in radiology reports, warranting a lightweight standard to obtain the necessary information from the Dose Management system.

The emergence of HL7 FHIR simplified the exchange between back end applications and other systems through the exchange of resources with stable structures. This IG facilitates the sharing of minimal dose information through FHIR Resources.

Scope

The defined profiles in this IG describe radiation information within a unique irradiation act, which may contain multiple irradiation events. This IG does not provide sufficient information to guide patient care decisions, or to influence decision making prior to prescribing studies.

In Scope:

  • Summary of dose information by exam through FHIR
  • Irradiation to which the patient was exposed
  • CT, XA, DX, RF, MG, NM

Out of Scope:

  • Details of radiation administration
  • Enhanced data (SSDE, Organ Dose, etc.)
  • Cumulative calculation of radiation over time
  • Irradiation to which the practitioner was exposed
  • Radiotherapy

Details of radiation administration (e.g., X-ray parameters, modality configuration, etc.) and enhanced data (e.g., size specific dose estimation), are available in DICOM Radiation Structured Reports (RDSRs).

Interpretation of radiation information may be influenced by several external factors not addressed in this IG.

The FHIR profiles defined in this IG are a solution to simplify sharing the radiation summary information between applications. This IG is not meant to describe how the radiation data is assessed or who can access and interpret it. Such interpretation requires domain expertise and additional data not available in RDSRs or RRDSRs. Implementers are urged to follow international and national regulations and recommendations, such as AAPM/ACR/HPS Joint Statement on Proper Use of Radiation Dose Metric Tracking for Patients Undergoing Medical Imaging Exams.

Use case: Imaging report construction

Use case 1: Imaging report construction


The main use case identified for this implementation guide is the following:

  • The modality transfers the dose report to the Dose Management System (i.e. IHE REM Dose Reporter).
  • After analyzing the study, the radiologist dictates a report within the Radiology Information System (RIS).
  • The RIS queries the Dose Management system to obtain a Dose Summary.
  • The RIS incorporates the Dose Summary into to the report.
  • The radiologist signs the final report.
  • The report is available in the hospital EHR.
  • Optionally (not shown), the report is shared with the regional/national radiology report repository.

Note: this case shows the RIS pulling (GET) the Dose Summary, it could also be pushed (PUT)

This case is common in RIS systems without a dose management module, in which gathering dose information from multiple sources can be complex due to:

  • multiple sources of data (e.g., RDSR, MPPS, SC & OCR, and DICOM image metadata), and
  • coercion of reported data in order to provide summary.

It is the role of the Dose Management system to provide the RIS with the correct information regarding the administered dose. Reporting the minimal dose information within the final imaging report is recommended by various organizations, and may be required by local regulation. For example:

  • French order of 22 September 2006 requires the report to provide information justifying the procedure,the operations carried out, as well as the data used to estimate the dose received by the patient.
  • California Senate bill Senate Bill No. 1237 requires “…health facilities and clinics that use imaging procedures that involve computed tomography X-ray systems (CT) for human use to record the dose of radiation on every CT study produced during a CT examination.”

Minimal Radiation Information

Identification

In this paragraph, we analyze the mapping between the identified minimal dose information and some specifications on dose information reporting coming from multiple stakeholders:

The analysis of the different specifications allowed to obtain the following coverage between the minimal dose information and these specifications/guidelines:

Dose Information

Modality

 

PS3.20

PS3.16

 

Finland

France

USA
California

CT

XA

RF

MG

NM

 

CT RDSR

X-Ray RDSR

RRDSR

TID 2008

 

Irradiation authorizing Person

 

 

 

 

 

 

Y

 

 

 

Y

 

 

Y

Y

Pregnancy Observation

 

 

 

 

 

 

Y

 

 

 

Y

 

 

Y

Y

Indication Observation

 

 

 

 

 

 

Y

 

 

 

Y

 

 

Y

 

Device

 

 

 

 

 

 

 

Y

Y

Y

 

 

 

Y

Y

Irradiation Issued Date

 

 

 

 

 

 

 

Y

Y

Y

 

 

 

Y

Y

Associated Procedure

 

 

 

 

 

 

 

Y

Y

Y

 

 

 

Y

 

Dose measurements - Study level

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dose (RP) Total

 

Y

Y

Y

 

 

Y

 

Y

 

 

 

Y

 

 

Accumulated Average Glandular Dose

 

 

 

Y

 

 

Y

 

Y

 

 

 

 

Y

 

Dose Area Product Total

 

Y

Y

Y

 

 

Y

 

Y

 

 

 

Y

Y

 

Fluoro Dose Area Product Total

 

Y

Y

Y

 

 

Y

 

Y

 

 

 

 

 

 

Acquisition Dose Area Product Total

 

Y

Y

Y

 

 

Y

 

Y

 

 

 

 

 

 

Total Fluoro Time

 

Y

Y

Y

 

 

Y

 

Y

 

 

 

 

 

 

Total Number of Radiographic Frames

 

Y

Y

Y

 

 

Y

 

 

 

 

 

 

 

 

CT Dose Length Product Total

Y

 

 

 

 

 

Y

Y

 

 

 

 

Y

Y

Y

Administered activity

 

 

 

 

Y

 

Y

 

 

Y

 

 

 

Y

 

Radiopharmaceutical Agent

 

 

 

 

Y

 

Y

 

 

Y

Y

 

 

Y

 

Radionuclide

 

 

 

 

Y

 

 

 

 

Y

 

 

 

Y

 

Radiopharmaceutical Volume

 

 

 

 

Y

 

 

 

 

Y

 

 

 

 

 

Route of administration

 

 

 

 

Y

 

 

 

 

Y

 

 

 

Y

 

Dose measurements - Irradiation Event level

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mean CTDIvol

Y

 

 

 

 

 

Y

Y

 

 

 

 

Y

 

Y

DLP

Y

 

 

 

 

 

 

Y

 

 

 

 

 

 

Y

Target Region

Y

 

 

 

 

 

 

Y

 

 

 

 

 

Y

Y

CTDIw Phantom Type

Y

 

 

 

 

 

 

Y

 

 

 

 

 

 

Y

Concepts mapping

The minimal dose information that should be collected by the Dose Management system and shared with third party applications are divided into contextual data and dose measurement data.

Contextual Information data:

Contextual Information Identifier Level
Irradiation Authorizing Person EV (113850, DCM, Irradiation Authorizing) Procedure
Pregnancy Observation EV (82810-3, LN, Pregnancy status) Procedure
Indication Observation EV (18785-6, LN, Indications for Procedure) Procedure
Irradiating Device EV (113859, DCM, Irradiating Device) Procedure
Irradiation Issued Date EV (113809, DCM, Start of X-Ray Irradiation) Procedure
Related Imaging Study EV (110180, DCM, Study Instance UID) Procedure

Dose measurements data:

Dose Measurements Identifier DICOM TID Level Type Unit/ValueSet
Dose (RP) Total EV (113725, DCM, Dose (RP) Total) TID 10007 Procedure Quantity mGy
Accumulated Average Glandular Dose EV (111637, DCM, Accumulated Average Glandular Dose) TID 10005 Procedure Quantity mGy
Dose Area Product Total EV (113722, DCM, Dose Area Product Total) TID 10007 Procedure Quantity mGy.cm2
Fluoro Dose Area Product Total EV (113726, DCM, Fluoro Dose Area Product Total) TID 10004 Procedure Quantity mGy.cm2
Acquisition Dose Area Product Total EV (113727, DCM, Acquisition Dose Area Product Total) TID 10004 Procedure Quantity mGy.cm2
Total Fluoro Time EV (113730, DCM, Total Fluoro Time) TID 10004 Procedure Quantity s
Total Number of Radiographic Frames EV (113731, DCM, Total Number of Radiographic Frames) TID 10007 Procedure Integer  
CT Dose Length Product Total EV (113813, DCM, CT Dose Length Product Total) TID 10012 Procedure Quantity mGy.cm
Administered activity EV (113507, DCM, Administered activity) TID 10022 Administration Quantity MBq
Radiopharmaceutical Agent EV (349358000, SCT, Radiopharmaceutical agent) TID 10022 Administration CodeableConcept Radiopharmaceuticals Value Set
Radionuclide EV (89457008, SCT, Radionuclide) TID 10022 Administration CodeableConcept Isotopes Value Set
Radiopharmaceutical Volume EV (123005, DCM, Radiopharmaceutical Volume) TID 10022 Administration Quantity cm3
Route of administration EV (410675002, SCT, Route of administration) TID 10022 Administration CodeableConcept Route of Administration
Mean CTDIvol EV (113830, DCM, Mean CTDIvol) TID 10013 Irradiation Event Quantity mGy
DLP EV (113838, DCM, DLP) TID 10013 Irradiation Event Quantity mGy.cm
Target Region EV (123014, DCM, Target Region) TID 10013 Irradiation Event CodeableConcept Anatomy Imaged
CTDIw Phantom Type EV (113835, DCM, CTDIw Phantom Type) TID 10013 Irradiation Event CodeableConcept Phantom Devices

Remarks:

  • We highlighted the “Dose (RP) Total” and not the “Entrance Exposure at RP”, as the latter one is related to the irradiation event level, and not the procedure level. Even if the PS3.20 is referencing the Entrance Exposure at RP, the IEC 61910-1 is referencing the Dose (RP) Total in the Basic Dose Documentation conformance.
  • For NM, most of the minimal dose information related to procedure are described in the irradiation event level of the RRDSR structure. However, as there is only one irradiation event per RRDSR, we considered that this minimal dose information is related to the procedure level. However, this implies that for the same NM imaging procedure, multiple Radiation Dose Summaries can be reported. This should not be a problem, as in this case the radiation dose summary is related to the administration act, more than the procedure act.
  • The irradiation Issued Date has different significations, based on the targeted procedure type; in CT, it is the start date of the irradiation act, in XA/RF/MG, it is the Series Date Time, and in NM, it is the administration date time.
  • The associated procedure is referenced through the related Imaging Study.
  • The calibration factors are not reported as part of the minimal dose information. The generator of the Dose Summary resources shall take in consideration these calibration factors.
  • Based on the analyzes performed, there is no minimal dose information related to the level Irradiation Event and part of the modalities XA/RF/MG.

Underlying specifications

This IG is based on HL7 FHIR standard, as well as DICOM standard, and its packaged value sets fhir.dicom. This IG uses also a profile from the specification International Patient Summary IG (IPS). Implementers of this specification must understand some basic information about the underlying specifications listed above.

FHIR

This IG uses terminology, notations and design principles that are specific to the HL7 FHIR standard. Before reading the page architecture and implementation, it is important to be familiar with the basic principles of FHIR and how to read FHIR specifications. Readers who are unfamiliar with FHIR are encouraged to review the following prior to reading the rest of this implementation guide.

This implementation guide supports the recently published FHIR R4 version of the FHIR standard to ensure alignment with the current direction of the FHIR standard.

FHIR resources used

The table below identifies the specific FHIR Resources and their purposes that will be used in this IG. Implementers should familiarize themselves with these FHIR resources and their purposes.

FHIR Resource Purpose
Observation Used to describe the radiation dose summary and the collected minimal dose information
Patient Used to reference the irradiated person
Practitioner Used to reference the related irradiation authorizing person
Device Used to describe the irradiating modality
ImagingStudy Used to reference the performed exam
Composition Used to create the irradiation report

DICOM® Standard

DICOM® is used as reference standard, as it provides a complete definition of the dose information that can be present in a radiation report. The DICOM® version used in this IG is the 2021d release. The packaged value sets coming from DICOM within fhir.dicom are referenced many times in the different profiles of this IG.

DICOM®

International Patient Summary IG (IPS)

Pregnancy Status Profile from International Patient Summary IG (IPS) is used within this IG in order to report a possible pregnancy of an irradiated person.

International Patient Summary IG (IPS)

Glossary

The following terms and acronyms are used within the Radiation Dose Summary IG:

Term Definition
AAPM American Association of Physicists in Medicine
ACR American College of Radiology
ATNA Audit Trail and Node Authentication
CDA Clinical Document Architecture
CDS Clinical Decision Support
CT Computed Tomography
CTDI Computed Tomography Dose Index
DAP Dose Area Product
DICOM Digital Imaging and Communications in Medicine
DLP Dose Length Product
EHR Electronic Health Record
EMR Electronic Medical Record
FHIR Fast Healthcare Interoperability Resources
HAS French High Authority of Health
HL7 Health Level Seven
HPS Health Physics Society
IEC International Electrotechnical Commission
IG Implementation Guide
IHE Integrating the Healthcare Enterprise
IOD Information Object Definition
IPS International Patient Summary
MG Mammography
MPPS Modality Performed Procedure Step
NM Nuclear Medicine
OCR Optical Character Recognition
PHI Personal Health Information
RDSC Radiation Dose Summary Consumer
RDSP Radiation Dose Summary Producer
RDSR Radiation Dose Structured Report
REM Radiation Exposure Monitoring
REM-NM Radiation Exposure Monitoring for Nuclear Medicine
REST Representational State Transfer
RF Radio Fluoroscopy
RIS Radiology Information System
RP Reference Point
RRDSR Radiopharmaceutical Radiation Dose Structured Report
SFR French Society of Radiology
SR Structured Report
SSDE Size Specific Dose Estimation
TID Template ID
TLS Transport Layer Security
UID Unique identifier
URL Uniform Resource Locator
URN Uniform Resource Name
VR Value Representation
XA X-Ray Angiography
XDS-I.b Cross-enterprise Document Sharing for Imaging

References

  1. DICOM, DICOM PS3.20: Imaging Reports using HL7 Clinical Document Architecture
  2. DICOM, DICOM PS3.16: Content Mapping Resource
  3. DICOM, X-Ray Radiation Dose SR IOD Templates
  4. DICOM, CT Radiation Dose SR IOD Templates
  5. DICOM, Radiopharmaceutical Radiation Dose SR IOD Templates
  6. DICOM, TID 2008. Radiation Exposure and Protection Information
  7. French Society of Radiology - SFR, Practical Guide for Interventional Radiology (Guideline - 2013)
  8. French High Authority of Health - HAS, Patient radiation protection and analysis of CPD practices and certification of healthcare establishments (Guideline - 2012)
  9. French nuclear safety authority, Presentation of the main radiation protection regulatory provisions applicable in medical and dental radiology (Guideline: 2016)
  10. French Minister of Health and Solidarity, Order of 22 September 2006 relating to the radiation information to be included in an act report using ionizing radiation, (Order - 2006)
  11. Finnish Imaging Report specification, KanTa Imaging CDA R2 document structures (2013)
  12. Finnish Radiation and Nuclear Safety Authority, Röntgentutkimuksesta potilaalle aiheutuvan säteilyaltistuksen määrittäminen (X-ray examination of the patient radiation exposure determination)
  13. AAPM, Computed Tomography Dose Limit Reporting Guidelines for Section 3 – 115113
  14. Senate Bill No. 1237, CHAPTER 521
  15. AAPM, Experience with California Law on Reporting CT Dose
  16. Radiologist Compliance With California CT Dose Reporting Requirements: A Single-Center Review of Pediatric Chest CT
  17. University of California Dose Optimization and Standardization Endeavor (UC-DOSE). Recommendations for compliance with California Senate Bill 1237 and related pending legislation
  18. IEC, IEC 61910-1:2014 - Medical electrical equipment - Radiation dose documentation - Part 1: Radiation dose structured reports for radiography and radioscopy
  19. IHE Radiology (RAD), Technical Framework Volume 1, Cross-enterprise Document Sharing for Imaging (XDS-I.b)
  20. IHE Radiology (RAD), Technical Framework Volume 1, Radiation Exposure Monitoring (REM)
  21. HL7 International, International Patient Summary Implementation Guide (IPS)
  22. AAPM/ACR/HPS, AAPM/ACR/HPS Joint Statement on Proper Use of Radiation Dose Metric Tracking for Patients Undergoing Medical Imaging Exams